RecruitingNCT05450718
Low-dose or standard buprenorphine start for opioid use disorder
About this title
Low-dose Buprenorphine Initiation for Opioid Use Disorder
Read the official source — NCT05450718Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- The BronxSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 11, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- Montefiore Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05450718
- Official title
Show the full official title
A Pilot Randomized Controlled Trial of Low-dose Buprenorphine Initiation for Opioid Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
The Bronx
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Montefiore Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including buprenorphine-naloxone.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
